Golgi membrane protein 1 (GOLM1) is a type II Golgi membrane protein discovered in recent years. The protein expression level increases in a variety of diseases and cancerous tissues. It is especially closely related to liver diseases. Many studies have shown that GOLM1 is more sensitive and more specific than alpha-fetoprotein (AFP, the most specific marker for primary liver cancer and the main indicator for the diagnosis of liver cancer) in the serological diagnosis of liver cancer. GOLM1 is expected to be the serological marker for the early diagnosis of liver cancer. It has also been reported to be highly expressed in patients with viral hepatitis and cirrhosis.
ABclonal Technology provides GOLM1 polyclonal antibodies that can be used for WB, IF, and IHC.